valuation

Is the New Pfizer an Attractive Investment?

Introduction Pharmaceutical giant Pfizer (PFE) is a company in transition that will soon be smaller but hopefully more profitable.  Since many of their established drugs are coming off patent, the company is divesting its older drug platform under the Upjohn brand and selling it to Mylan a leading generic pharmaceutical company.  Pfizer believes that this …

Passive and Buy-And-Hold Investing Don’t Work Unless!

Introduction Legendary investor and mentor to many investing greats Benjamin Graham once aptly stated that: “investing is most intelligent when it is most businesslike.”  Personally, I agree which is why I refer to what I personally adhere to and practice with my own investing as “business perspective investing.”  Stated more directly, I do not believe …

The Right Way to Value Growth Stocks: Part 3

 Introduction In part 2 of this series I focused on how to value slow and moderately growing businesses. In this article, Part 3, I will shift my focus on how to value faster growing companies (growth stocks).  My definition of a fast grower (growth stock) is one that has consistently compounded earnings at 15% per annum or …

Why A 15 P/E Ratio Is Fair Value for Most Companies: Part 2

Introduction To me, fair value, as it relates to common stock investments, is manifest when the current earnings yield provided by the company’s profits compensates me for the risk I am taking by providing both a realistic and acceptable return on my invested capital.  Most importantly, as will be explained later, current earnings yield and …

The Essence of Valuation is Soundness Not Rate of Return: Part 1

Introduction on Stock Valuation When it comes to writing about investing in common stocks, my favorite theme typically revolves around valuation.  In fact, I once had a reader dub me “Mr. Valuation.”  Which, I might add was very flattering to me.  Moreover, in the context of discussing valuation, there are normally three concepts that are …

Microsoft Important Lessons in Valuation: Part 1

Introduction Before I get too deep into this article, I want to start out by stating that Microsoft (MSFT) has long been one of my favorite companies.  Many years ago, I invested in Microsoft as a pure growth stock and sold it in 2000 when it became dangerous overvalued after making a very healthy long-term …